Alarm As Novartis Exits Antibiotics Space

 
• By Kevin Grogan
  
Book keeper
Antibiotic R&D costs do not add up for Novartis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anti-infective

More from Therapy Areas